Bg pattern

VERRUPATCH 3.75 mg CUTANEOUS PATCHES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use VERRUPATCH 3.75 mg CUTANEOUS PATCHES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: information for the user

Verrupatch 3.75mg transdermal patches

salicylic acid

Read the entire leaflet carefully before starting to use this medicine, as it contains important information for you.

Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 7 days.

Contents of the leaflet

  1. What is Verrupatch and what is it used for
  2. What you need to know before using Verrupatch
  3. How to use Verrupatch
  4. Possible side effects
  5. Storage of Verrupatch
  6. Package contents and additional information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Verrupatch and what is it used for

Verrupatch is a medicine in the form of transdermal patches and belongs to the group of anti-wart medicines.

It contains salicylic acid as the active ingredient, with anti-wart properties due to its keratolytic activity, which produces softening and subsequent destruction of the stratum corneum, allowing the elimination of warts.

Verrupatch is indicated for the local treatment of common warts, which usually appear on the hands or feet (plantar warts).

2. What you need to know before using Verrupatch

Do not use Verrupatch

  • If you are allergic to salicylic acid or any of the other components of this medicine (listed in section 6).
  • Do not apply to moles, birthmarks, warts with hair, genital warts, warts on the face or mucous membranes.
  • Do not use this product on irritated or wounded skin or on any area that is infected, inflamed, or reddened.
  • Do not use in children under 2 years of age.
Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Warnings and precautions

Consult your doctor or pharmacist before starting to use Verrupatch.

Do not ingest. For cutaneous use (exclusively on the skin).

Avoid contact with healthy skin.

Avoid contact with the eyes.

In case of accidental application to the eyes, rinse with plenty of water.

Diabetic or poorly circulated individuals should consult their doctor before using this medicine.

Children

Do not use in children between 2 and 12 years old without medical advice (see Do not use Verrupatch).

Young children may be at greater risk of side effects.

Other medicines and Verrupatch

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.

Do not use this medicine together with other keratolytics (anti-wart medicines) in the same area, as they may enhance its effect.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Do not use Verrupatch during pregnancy, except for short-term treatment of a small wart.

Oral forms (e.g., tablets) of this class of medicine may cause side effects in the fetus. It is unknown if the same risks apply to Verrupatch when used for warts.

A decision should be made whether to discontinue breastfeeding or discontinue treatment, considering the benefit of breastfeeding for the child and the benefit of treatment for the mother.

C

Verrupatch has no or negligible influence on the ability to drive and use machines.

Verrupatch contains propylene glycol (E-1520)

This medicine contains 11.25 mg of propylene glycol in each dose unit (patch).

Propylene glycol may cause skin irritation.

3. How to use Verrupatch

Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

For cutaneous use (on the skin).

The recommended dose is one Verrupatch patch once a day, preferably before bedtime.

Use in children

Do not use in children under 2 years of age.

In children under 12 years of age and over 2 years, do not use without medical advice and avoid prolonged use in children.

Instructions for correct administration

Hand holding an auto-injector pen with the tip applied to the skin of the abdomenHand holding a syringe with a needle inserted into the skin showing the angle of subcutaneous injection

Two hands holding an auto-injector with the thumb pressing the activation button

  1. Before applying the patch, it is recommended to file the surface of the wart with the file included in the package.
  1. Moisten the area to be treated with water.
  1. Apply the patch so that the non-blue part comes into direct contact with the wart. If necessary, cut to fit so that it only covers the wart and does not touch the surrounding tissue.

Hand holding a syringe with a needle inserted into the skin fold at a 90-degree angle

  1. Fix the patch using the adhesive strip provided.

Hand holding a syringe with a needle inserted into the skin showing the angle of subcutaneous injection

Human foot with toes outlined showing the sole and general outline

Hand holding a syringe with a needle inserted into the skin at an inclined angle for subcutaneous injection

Hand holding a syringe with a needle inclined downward ready for intramuscular injectionLeave the patch on for the night (about 8 hours) and remove it in the morning. Repeat this process daily, for a maximum of 12 weeks, until the wart is eliminated. Generally, a noticeable improvement occurs during the first few days, so a complete resolution can be expected after a period of 3 to 6 weeks of treatment.

Consult your doctor or pharmacist if you do not notice an improvement after 1 week, or if the warts are numerous or if an infection or inflammation occurs.

If you use more Verrupatch than you should

Overdose cases are not expected due to the mode of application of this medicine. Excessive use may cause irritation, especially on healthy skin. Use emollients if necessary.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call a medical center or the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount used.

If you forget to use Verrupatch

Do not apply a double dose to make up for forgotten doses. Apply the product again at your usual time

If you stop treatment with Verrupatch

If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone may experience them.

Local irritation may occur if the patches come into contact with the healthy skin surrounding the wart. In this case, it is recommended to temporarily suspend treatment until the irritation disappears. When resuming treatment, make sure the patch is properly cut to only come into contact with the wart tissue.

Excessive scaling has been reported in application to open lesions; also, serious allergic reactions.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Verrupatch

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Do not use this medicine after the expiration date shown on the package after CAD. The expiration date is the last day of the month indicated.

Do not use this medicine if you notice visible signs of deterioration in the appearance of the transdermal patches.

Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Verrupatch

  • The active ingredient is salicylic acid. Each patch contains 3.75 mg of salicylic acid.
  • The other ingredients (excipients) are: propylene glycol (E-1520), karaya gum, polyethylene glycol 300 (Macrogol 300), and quaternium-15.

Appearance of the product and package contents

Verrupatch is presented in the form of circular transdermal patches, 6 mm in diameter, beige in color, and covered with a blue polyethylene film that retains moisture, exerting an occlusive effect.

Each package contains 20 patches arranged in two hermetically sealed, moisture-resistant pouches, with 10 patches each.

To fix the patches in the correct position, 20 dermocompatible adhesive strips are included. A file is also provided to remove any remaining material from the surface of the wart.

Marketing authorization holder

Laboratorios Viñas, S.A.

Provenza, 386

08025 - Barcelona

Spain

Manufacturer

Laboratorios Viñas, S.A.

Torrente Vidalet, 29

08012- Barcelona

Spain

Date of the last revision of this leaflet:November 2024

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/

Online doctors for VERRUPATCH 3.75 mg CUTANEOUS PATCHES

Discuss questions about VERRUPATCH 3.75 mg CUTANEOUS PATCHES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (760)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for VERRUPATCH 3.75 mg CUTANEOUS PATCHES?
VERRUPATCH 3.75 mg CUTANEOUS PATCHES does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures VERRUPATCH 3.75 mg CUTANEOUS PATCHES?
VERRUPATCH 3.75 mg CUTANEOUS PATCHES is manufactured by Laboratorios Vinas S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of VERRUPATCH 3.75 mg CUTANEOUS PATCHES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether VERRUPATCH 3.75 mg CUTANEOUS PATCHES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to VERRUPATCH 3.75 mg CUTANEOUS PATCHES?
Other medicines with the same active substance () include ADTRALZA 150 mg PRE-FILLED SYRINGE SOLUTION FOR INJECTION, ADTRALZA 300 mg Injectable Solution in a Pre-filled Pen, ALITRETINOIN IFC 10 mg SOFT CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media